Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Suda Tatsuo is active.

Publication


Featured researches published by Suda Tatsuo.


Molecular and Cellular Endocrinology | 1990

Interleukin 1 regulates the expression of osteopontin mRNA by osteoblasts

Cheng He Jin; Miyaura Chisato; Ishimi Yoshiko; Mei Hua Hong; Sato Toshiyuki; Abe Etsuko; Suda Tatsuo

Osteopontin is a matrix protein which belongs to the integrin superfamily and is involved in cell adhesion. In the present study, we examined the regulation of the mRNA expression of osteopontin by interleukin 1 alpha (IL-1 alpha) in osteoblasts. IL-1 alpha greatly increased the steady-state level of osteopontin mRNA in both a mouse osteoblastic cell line (MC3T3-E1) and mouse primary osteoblast-like cells. The increase in the osteopontin mRNA expression by IL-1 alpha was dose-dependent at a range of 0.004-0.2 nM. This was most likely due to an increase in the transcriptional rate, not to an increase in the stability of osteopontin mRNA. The in vitro nuclear transcription experiment showed that IL-1 alpha-treated MC3T3-E1 cells increased the synthesis of osteopontin mRNA. Besides IL-1 alpha, tumor necrosis factor alpha (TNF-alpha), lipopolysaccharides (LPS) and 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) increased the osteopontin mRNA expression in both the clonal osteoblasts (MC3T3-E1) and the primary osteoblast-like cells. In response to such bone-resorbing agents, primary osteoblast-like cells expressed osteopontin mRNA much more strongly than primary fibroblast-like cells isolated from mouse calvaria. Both IL-1 alpha and 1 alpha,25(OH)2D3 greatly increased the production of 68 and 62 kDa phosphoproteins in conditioned media of MC3T3-E1 cell cultures, which probably correspond to osteopontin. These results suggest that osteopontin plays an important role in bone remodeling, in particular bone resorption.


Biochimica et Biophysica Acta | 1994

Biological activities of 24-fluoro-1α,25-dihydroxyvitamin D-2 and its 24-epimer

Imae Yuko; Manaka Akihiko; Yoshida Norio; Ishimi Yoshiko; Shinki Toshimasa; Abe Etsuko; Suda Tatsuo; Konno Katsuhiro; Takayama Hiroaki; Yamada Sachiko

Abstract Biological activities of two epimeric 24-fluorinated vitamin D-2 analogs, 24-fluoro-1α,25-dihydroxyvitamin D-2 [24-F-1,25-(OH) 2 D 2 ] and its 24-epimer [24-epi-24-F-1,25-(OH) 2 D 2 ], were studied and compared with 1α,25-dihydroxyvitamin D-3 [1,25-(OH) 2 D 3 ] and 1α,25-dihydroxyvitamin D-2 [1,25-(OH) 2 D 2 ]. 24-F-1,25-(OH) 2 D 2 was nearly as active as 1,25-(OH) 2 D 3 and 1,25-(OH) 2 D 2 both in regulating calcium metabolism in vivo including bone mineral mobilization and intestinal calcium transport and in inducing differentiation of HL-60 cells. While 24-epi-24-F-1,25-(OH) 2 D 2 showed distinct properties in these two types of the actions. Though the 24-epimer was nearly as potent as 1,25-(OH) 2 D 3 in inducing differentiation of HL-60 cells, it showed little activity in regulating calcium metabolism in vivo. The fluorine atom introduced at the 24-position of either 1,25-(OH) 2 D 2 or its 24-epimer had no potentiating effect. This is in sharp contrast with the cases of 24- and 26,27-multifluorinated analogs of active vitamin D-3.


Archive | 1983

5,6-epoxidized vitamin d3 derivative

Takayama Hiroaki; Yamada Sachiko; Nakayama Keiko; Suda Tatsuo


Archive | 1981

Tumor-suppressing agent

Suda Tatsuo; Hirasawa Yoshihei; Takahashi Yukio; Abe Etsuko; Konno Kunio; Aoki Tadao


Archive | 1976

1 ARUFUA* 2 ARUFUAA JIHIDOROKISHIKOREKARUSHIFUEROORUNO SEIHO

Ishikawa Masayuki; Kaneko Chikara; Suda Tatsuo; Yamada Sachiko; Sugimoto Akiko; Sasaki Satoru


Archive | 1976

1ALPHA, 2ALPHA-DIHYDROXYCHOLECALCIFEROL, VERFAHREN ZU SEINER HERSTELLUNG UND DIESE VERBINDUNG ENTHALTENDE ARZNEIPRAEPARATE

Ishikawa Masayuki; Kaneko Chikara; Sasaki Satoshi; Suda Tatsuo; Yamada Sachiko; Sugimoto Akiko


Archive | 1996

FLUORINATED VITAMIN D DERIVATIVE AND ITS PRODUCTION

Hosoya Ryuzo; Iwasaki Hiroshi; Miyamoto Yoichi; Yamada Sachiko; Yamamoto Keiko; Suda Tatsuo; Araki Toshimasa


Archive | 2006

BONE RESORPTION INHIBITOR INCLUDING INTERLEUKIN-6 RECEPTOR ANTIBODY AS ACTIVE INGREDIENT

Kishimoto Chuzo; Miyaura Chisato; Suda Tatsuo


Archive | 1999

25-HYDROXYVITAMIN D3-1-ALPHA-HYDROXYLASE AND DNA ENCODING THE SAME

Anazawa Hideji; Shimada Hiroko; Sugimoto Seiji; Suda Tatsuo; Araki Toshimasa; Saruta Yukio; Ishimura Tatsumi; Hayashi Matsuhiko; Wakino Osamu; Kadokawa Toshiaki; Yoshida Osamu; Suzuki Hiromichi


Archive | 1995

BONE ABSORPTION INHIBITOR COMPRISING INTERLEUKIN 6 RECEPTOR ANTIBODY AS ACTIVE INGREDIENT

Kishimoto Chuzo; Miyaura Chisato; Suda Tatsuo

Collaboration


Dive into the Suda Tatsuo's collaboration.

Top Co-Authors

Avatar

Yamada Sachiko

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ishikawa Masayuki

Wisconsin Alumni Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Kaneko Chikara

Wisconsin Alumni Research Foundation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sasaki Satoshi

Wisconsin Alumni Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Sugimoto Akiko

Wisconsin Alumni Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Eguchi Yukuo

Wisconsin Alumni Research Foundation

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge